Search
for
Sort by
Research 301–330 of 1000+
- Mucocutaneous side effects of antineoplastic chemotherapy
- Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- Salvage Chemotherapy in Follicular Non-Hodgkin's Lymphoma: Focus on Tolerability
- Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma
- Equivalent chemotherapy efficacy against leukemia in mice treated with topical vasoconstrictors to prevent cancer therapy side effects
- Cancer Chemotherapy: an Introduction
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy
- Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
- The Chemotherapy Use and Adverse Effects of Patients with Lung Cancer at Regional General Hospital in Surabaya, Indonesia
- The Chemotherapy Use and Adverse Effects of Patients with Lung Cancer at Regional General Hospital in Surabaya, Indonesia
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Pediatric Ewing's Sarcoma and Permanent Chemotherapy‐Induced Alopecia: A Case–Control Study
- 51895 Interim Analysis of Platelet-Rich Plasma (PRP) Treatment for Endocrine Therapy-Induced Alopecia (EIA) and Permanent Chemotherapy-Induced Alopecia (pCIA) in Breast Cancer Patients: A Randomized Controlled Trial
- Abstract P5-21-05: ERALOP study: Post adjuvant FEC - docetaxel chemotherapy for early breast cancer: Hair regrowth in the real life
- Photo (Chemo) Therapy and Vitiligo
- Cutaneous complications of chemotherapeutic agents
- Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
- Oral toxicity produced by chemotherapy: A systematic review
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Cutaneous Reactions to Chemotherapeutic Agents
- Mechanisms underlying select chemotherapeutic-agent-induced neuroinflammation and subsequent neurodegeneration
- Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
- Clinically-Relevant Chemotherapy Interactions with Complementary and Alternative Medicines in Patients with Cancer
- Therapeutic efficacy and safety of Kang-ai injection combined with platinum-based doublet chemotherapy in advanced NSCLC: A meta-analysis
- New potential chemotherapy for ovarian cancer — Combined therapy with WP 631 and epothilone B
- Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy
- Effect of FOLFOX6 chemotherapy on serum VEGF expression in advanced colorectal cancer patients
- Results of Ifosfamide Combination Chemotherapy in Patients with Advanced Soft Tissue Sarcomas